Audrey Z. Fu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Audrey Z. Fu has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
A. Napolitano
1 shared publication- Georgeina L. Jarman
Cambridge Liver Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
1 shared publication - Isabelle Justine Monique Williams
Core Surgical Trainee, Guy's and St Thomas’ NHS Foundation Trust London UK
1 shared publication - Karl Peter Sylvester
Respiratory Physiology, Papworth Hospital NHS Foundation Trust, Cambridge, UK
1 shared publication - Lauren C. Y. Tang
Victorian Liver Transplant Unit Austin Health Heidelberg Victoria Australia
1 shared publication - Matthew Hoare
Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, UK
1 shared publication
Latest Publications
- Open Access
- 20 October 2026
- Published by Elsevier in ESMO Gastrointestinal Oncology
- Vol. 14
GIST in Turner Syndrome
- 20 October 2026
- Published by Elsevier in ESMO Gastrointestinal Oncology
- Vol. 14
Open AccessGIST in Turner Syndrome
- Open Access
- 24 February 2026
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 32 (10) , 1400-1412
Pulmonary function test parameters before liver transplantation predict post-transplant survival and respiratory-related death
Pulmonary function tests (PFTs) are performed ahead of listing for liver transplantation (LT) to assess respiratory fitness for transplantation. We aimed to establish whether pre-transplant PFTs were associated with post-LT overall survival and respiratory cause of death. A single-center retrospective study of patients transplanted between 2014 and 2023 was performed. Cox regression was used to analyze the relationship between PFT parameters, normalized for age, sex, ethnicity, and overall post-transplant survival. Competing risks regression was used to analyze the relationship between PFT parameters and respiratory death post-LT. Pre-transplant PFTs from 772 LT recipients were studied (33% female, median age 58 y, indication for transplant: alcohol-associated liver disease in 28.3%, metabolic dysfunction–associated steatotic liver disease in 18.0%). When combined with clinical variables, PFT parameters were predictive of post-transplant overall survival and respiratory death. Lower forced expiratory volume in 1 second (FEV1) (aHR 0.85, 95% CI 0.73–0.99, p =0.04), increased age at transplant (aHR 1.03, 95% CI 1.01–1.05, p =0.01), and current smoking at time of assessment (aHR 1.95, 95% CI 1.08–3.54, p =0.03) were independently associated with poorer post-transplant survival. Whereas both single-breath diffusing capacity of the lung (DLCO SB) (aSHR 0.66, 95% CI 0.52–0.82, p p =0.001) were independent predictors of post-LT respiratory cause of death. In conclusion, a lower FEV1 z -score was independently associated with poorer post-LT overall survival, and a lower DLCO SB z -score was associated with respiratory cause of death post-LT, supporting the routine use of PFTs in pre-liver transplant assessment.
- 24 February 2026
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 32 (10) , 1400-1412
Open AccessPulmonary function test parameters before liver transplantation predict post-transplant survival and respiratory-related death
Pulmonary function tests (PFTs) are performed ahead of listing for liver transplantation (LT) to assess respiratory fitness for transplantation. We aimed to establish whether pre-transplant PFTs were associated with post-LT overall survival and respiratory cause of death. A single-center retrospective study of patients transplanted between 2014 and 2023 was performed. Cox regression was used to analyze the relationship between PFT parameters, normalized for age, sex, ethnicity, and overall post-transplant survival. Competing risks regression was used to analyze the relationship between PFT parameters and respiratory death post-LT. Pre-transplant PFTs from 772 LT recipients were studied (33% female, median age 58 y, indication for transplant: alcohol-associated liver disease in 28.3%, metabolic dysfunction–associated steatotic liver disease in 18.0%). When combined with clinical variables, PFT parameters were predictive of post-transplant overall survival and respiratory death. Lower forced expiratory volume in 1 second (FEV1) (aHR 0.85, 95% CI 0.73–0.99, p =0.04), increased age at transplant (aHR 1.03, 95% CI 1.01–1.05, p =0.01), and current smoking at time of assessment (aHR 1.95, 95% CI 1.08–3.54, p =0.03) were independently associated with poorer post-transplant survival. Whereas both single-breath diffusing capacity of the lung (DLCO SB) (aSHR 0.66, 95% CI 0.52–0.82, p p =0.001) were independent predictors of post-LT respiratory cause of death. In conclusion, a lower FEV1 z -score was independently associated with poorer post-LT overall survival, and a lower DLCO SB z -score was associated with respiratory cause of death post-LT, supporting the routine use of PFTs in pre-liver transplant assessment.